4 spatial transcriptomics trends defining the 2026 drug discovery cycle
By early 2026, the ability to map gene expression within its physical tissue context has transitioned from a niche research tool to a cornerstone of clinical pathology. Under new European Medicines Agency (EMA) directives, Spatial Genomics And Transcriptomic Market data is now frequently included in regulatory submissions for immunotherapy. This shift is enabling researchers in...
0 Yorumlar 0 hisse senetleri 399 Views 0 önizleme